Angiotech Pharmaceuticals Inc.’s (OTC:ANPI) shares are no longer traded on NASDAQ as of today.
The Vancouver-based company failed to regain compliance with the stock exchange’s listing rules within a 180-day period that ended Jan. 3.
NASDAQ warned the company (PDF) in July about its requirement for a minimum bid price of $1 for listed securities.